Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.990
+0.080 (1.63%)
At close: Jul 10, 2026, 4:00 PM EDT
4.840
-0.150 (-3.01%)
After-hours: Jul 10, 2026, 4:07 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $399.34 million as of July 10, 2026. Its market cap has increased by 34.47% in one year.
Market Cap
399.34M
Enterprise Value
142.76M
1-Year Change
34.47%
Ranking
Category
Stock Price
$4.99
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $399.34M, a decrease of -79.39%. That is a compound annual growth rate of -24.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 399.34M | 43.18% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cybin | 414.67M |
| Puma Biotechnology | 409.74M |
| vTv Therapeutics | 408.27M |
| DiaMedica Therapeutics | 408.17M |
| Century Therapeutics | 406.70M |
| Adlai Nortye | 406.00M |
| Upstream Bio | 404.88M |
| Enanta Pharmaceuticals | 395.47M |